Explain this page
Arphra AIPlain-English read on Colgate-Palmolive Company’s valuation06-08today
- Procter & Gamble vs. Colgate-Palmolive: One Dividend Giant Stands Above the Rest2d
- Will Colgate's Strategic Efforts and Innovation Bolster Growth?4d
- Forget P&G: This Defensive Cash-Flow Powerhouse Just Beat Earnings and Is a Best Buy Today5d
- 3 Dividend Kings With Income, Stability, and a Possible Catalyst5d
AI Issuer Brief
Arphra AILoading cached brief…
Fair value
Football field →Weighted blend
$677.03
+656.62% vs spot
Recommendation
Strong Buy
17 of 19 methods
Method spread
8bull9bear
±5% threshold
Analyst PT consensus: $93.70 (+4.72%)
Candlestick · 1Y
Open in chart workstation →CL
89.48+0.91%H 99.33L 74.55MA50 87.23MA200 84.40Avg vol 6.0M
Price change · trailing returns
Live| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.21% | +0.21% | -1.06% | +5.12% | +14.19% | +13.24% | +0.91% | +15.28% | +9.87% | +24.62% | +9579.06% |
Insider · 30d
History →Bought
$0
0 txns
Sold
$25.35M
10 txns
Net flow
−$25.35M
Aftermarket
LiveLast trade
$89.84
83 sh
Bid
$83.00
1 sh
Ask
$96.15
100 sh
Spread
$13.150
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q1 Mar 2026 | $5.32B | $646M | $0.80 |
| Q4 Dec 2025 | $5.23B | -$37M | $-0.05 |
| Q3 Sep 2025 | $5.13B | $735M | $0.91 |
| Q2 Jun 2025 | $5.11B | $743M | $0.91 |
| Q1 Mar 2025 | $4.91B | $690M | $0.85 |
| Q4 Dec 2024 | $4.94B | $739M | $0.90 |
Analyst view
DB · price_targets + analyst_gradesConsensus target
$93.70
+4.72% upside
Low
$79.00
Median
$93.50
High
$102.00
Recent actions
0 ↑0 ↓8 hold
- May 01, 2026
- Apr 01, 2026
- Mar 01, 2026
- Feb 01, 2026
- Jan 01, 2026
News
DB · news_items- Procter & Gamble vs. Colgate-Palmolive: One Dividend Giant Stands Above the Rest247wallst.com·Jun 19, 2026
- Will Colgate's Strategic Efforts and Innovation Bolster Growth?zacks.com·Jun 17, 2026
- Forget P&G: This Defensive Cash-Flow Powerhouse Just Beat Earnings and Is a Best Buy Today247wallst.com·Jun 16, 2026
- 3 Dividend Kings With Income, Stability, and a Possible Catalystmarketbeat.com·Jun 16, 2026
- 3 Consumer Staples Stocks to Buy Before the End of June247wallst.com·Jun 14, 2026
- Colgate Declares Regular Quarterly Dividendbusinesswire.com·Jun 11, 2026
- Colgate Declares Regular Quarterly Dividendbusinesswire.com·Jun 11, 2026
- NYSE Content Update: PointFive Raises $60 Million to Redefine Efficiencyprnewswire.com·Jun 08, 2026
Recent analyst activity
DB- Jun 11, 2026GradeMarket PerformColgate-Palmolive initiated with Market Perform on valuation at BernsteinBernstein
- Jun 11, 2026PT$96.00Colgate-Palmolive initiated with Market Perform on valuation at BernsteinBernstein
Financial scores
DBJun 20, 2026Altman Z
6.86
Safe
≥ 3.0 safe · 1.81–3.0 grey · < 1.81 distress
Piotroski F
7/9
Strong
≥ 7 strong · 4–6 average · < 4 weak
Peers
- MDLZMondelez International, Inc.$61.37$78.78B
- MNSTMonster Beverage Corporation$77.12$75.42B
- DEODiageo plc$79.70$44.28B
- KRThe Kroger Co.$67.77$42.89B
- CCEPCoca-Cola Europacific Partners PLC$94.18$42.2B
- KVUEKenvue Inc.$17.43$33.46B
- KMBKimberly-Clark Corporation$97.67$32.42B
- ELThe Estée Lauder Companies Inc.$79.30$28.68B
Total assets
$16.33B
Total debt
$7.99B
Cash & equiv
$1.29B
Operating CF
$4.2B
Free cash flow
$3.63B
Buybacks
-$1.21B
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
Tsourapas Panagiotis officer: COO, Eur., APac, Afr Eur, Skin | Sell | 15,000 | $1.47M | Feb 12, 2026 |
Tsourapas Panagiotis officer: COO, Eur., APac, Afr Eur, Skin | Sell | 35,000 | $3.31M | Feb 11, 2026 |
Hazlin John officer: Chief Growth Officer | Sell | 20,989 | $1.98M | Feb 10, 2026 |
Malcolm Gregory officer: EVP and Controller | Sell | 12,747 | $1.21M | Feb 06, 2026 |
Massey Sally officer: Chief Human Resources Officer | Sell | 15,851 | $1.51M | Feb 05, 2026 |
Wallace Noel R. director, officer: Chairman, President & CEO | Sell | 45,568 | $4.28M | Feb 04, 2026 |
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|---|---|---|---|---|
| FY 2025 | $20.38B | $4.35B | $2.13B | $2.63 | +10.46% |
| FY 2024 | $20.1B | $4.38B | $2.89B | $3.51 | +14.37% |
| FY 2023 | $19.46B | $4.13B | $2.3B | $2.77 | +11.82% |
| FY 2022 | $17.97B | $3.59B | $1.79B | $2.13 | +9.93% |
| FY 2021 | $17.42B | $3.89B | $2.17B | $2.55 | +12.43% |